ReproNovo SA | Finanzwire

Basculer en Français

11125	Companies
245038	Keywords
173144	Articles
132168	Press releases

Home
Companies
ReproNovo SA

BRIEF

published on 05/21/2025 at 07:05, 1 year 4 months ago

ReproNovo Secures $65 Million for Phase 2 Trials in Reproductive Health

Innovation Clinical Trials Series A Financing Reproductive Health ReproNovo
PRESS RELEASE

published on 05/21/2025 at 07:00, 1 year 4 months ago

REPRONOVO RAISES $65 MILLION SERIES A FINANCING TO ADVANCE PHASE 2 CLINICAL TRIALS OF NOVEL THERAPIES IN REPRODUCTIVE MEDICINE AND WOMEN’S HEALTH
ReproNovo raises $65 million in Series A financing to advance Phase 2 clinical trials of novel therapies in reproductive medicine and women’s health

Series A Financing Phase 2 Trials Women's Health ReproNovo Reproductive Medicine

Accesswire

Published on 10/05/2026 at 14:45, 3 hours 37 minutes ago

NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Published on 10/05/2026 at 14:30, 3 hours 52 minutes ago

Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
Published on 10/05/2026 at 14:30, 3 hours 52 minutes ago

Solitario CEO to Present at John Tumazos Very Independent Research, LLC
Published on 10/05/2026 at 14:00, 4 hours 22 minutes ago

Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
Published on 10/05/2026 at 14:00, 4 hours 22 minutes ago

GameSquare to Present at Upcoming Investor Conferences

View all ACCESSWIRE

EQS Group

Published on 10/05/2026 at 18:00, 22 minutes ago

2CRSi SA: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital as of September 30, 2026
Published on 10/05/2026 at 17:45, 37 minutes ago

BILENDI: Bilendi unveils major evolution for BARI AI in its Bilendi Discuss platform
Published on 10/05/2026 at 17:07, 1 hour 14 minutes ago

Amprion successfully issues more green bonds worth EUR 1.5 billion
Published on 10/05/2026 at 15:50, 2 hours 32 minutes ago

EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease
Published on 10/05/2026 at 15:49, 2 hours 32 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Senior PLC

Les Echos

Published on 10/05/2026 at 18:13, 9 minutes ago

Disclosure of shares outstanding and voting rights - 05.10.2026
Published on 10/05/2026 at 17:45, 37 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 10/05/2026 at 17:45, 37 minutes ago

Declaration of voting rights at the end of September 2026
Published on 10/05/2026 at 17:45, 37 minutes ago

Weekly share buyback
Published on 10/05/2026 at 17:18, 1 hour 4 minutes ago

voting rights

View all LES ECHOS COMFI WIRE